GSK

We are honoured to have supported the 2024 #WellChildAwards yesterday, recognising inspirational young people, their carers and healthcare professionals. Congratulations to all of the winners for their courageousness and determination. Find out how together with community partners we’re making a positive impact on the health of vulnerable and marginalised people. https://lnkd.in/eybmD2Fd   #AheadTogether

It’s been a busy week at the 79th United Nations General Assembly (UNGA) and New York Climate Week! Heads of state, community leaders and representatives from industry are amongst those that have come together with a collective determination and commitment to tackle antimicrobial resistance (AMR). AMR is one of the most significant threats to health globally and without meaningful action by 2050, almost 40 million lives will have been lost. And, shockingly, as a result of AMR, life expectancy globally could be reduced by nearly 2 years. That’s why this week, we’ve championed the importance of innovation, sustainable access to appropriate antibiotics, responsible manufacturing and prevention measures to stop infections in the first place. But it’s also clear that tackling AMR goes beyond what any one organisation can do; it requires a multi-sectorial approach and collaboration between governments, the private sector, healthcare professionals, researchers, and communities. By combining our efforts, we can get ahead of AMR together. #UNGA79 #AMR #Collaboration #Innovation Find out more: https://gsk.to/4gA0kBf

Mark your calendars for Monday as we come together to celebrate the incredible young people and healthcare professionals at the 2024 #WellChildAwards. Join us as we honour their resilience and dedication. By supporting WellChild, we are helping them reach as many children as they can, providing a lifeline to UK families experiencing complex and serious illness. To learn more: https://gsk.to/3XZlOQH #AheadTogether

Together, with world leaders, we’ve been discussing the role innovation can play to get ahead of some of the most urgent global threats, such as antimicrobial resistance. Hear from our CEO, Emma Walmsley, as she shares her reflections from #UNGA79. Find out more: https://gsk.to/4elRB46

Everyone has a role to play in addressing the critical challenges we face when it comes to antimicrobial resistance (AMR). At #UNGA79, we joined AMREF and Devex in a discussion addressing the challenges of antimicrobial resistance (AMR). Together with Yewande Alimi, Vivian Nabisere, margaret odera, Prof Mirfin Mpundu, Dr. Githinji Gitahi and our VP of Global Health, Fiona Smith-Laittan, we explored the barriers to tackling AMR in Africa and the importance of a One Health approach to help get ahead of this huge challenge across the continent. The conversation highlighted the critical role of primary healthcare and the healthcare workforce in responding to this crisis and put a spotlight on the need to scale up local solutions to inform an African-led response to AMR. Thanks to everyone who came together to share their insights, priorities and actions needed to help #ChangeTheTrajectory of AMR in lower income countries. These important conversations won’t stop here. Later today our CEO, Emma Walmsley, will participate in the High-Level Meeting on AMR– follow for more on this, and other updates right here: https://gsk.to/4ehh0fb Africa CDC, African Youth Antimicrobial Resistance Alliance Task Force (AYARA-TF), Ministry of Health, Kenya, USAID

Climate change is an urgent threat to human health. We’ve set an ambitious goal to reach net zero impact on climate change across our full value chain by 2045 – and we’re taking action to achieve it. Around a third of our total emissions come from our supply chain, which is why we co-founded Energize, a healthcare industry programme to support suppliers to access renewable energy. We are thrilled that the first deal has been announced and that it includes four of GSK’s suppliers in Europe. The deal will support seven new solar energy projects in Spain and bring additional renewable capacity to the European grid. This is one of the ways we’re working to create more sustainable healthcare that is better for patients and the planet. Find out more: https://gsk.to/47NbeiT #ClimateWeekNYC

We’re at #UNGA79, where equitable access to healthcare is high on the agenda. Our Chief Global Health Officer, Thomas Breuer, MD, MSc, is here and shares how we must approach global health challenges together, if we’re to get ahead of the world’s biggest epidemics like malaria as well as tackling antimicrobial resistance.  🔗 Check out what’s still to come from us in New York: https://gsk.to/3XYZHZx

Through research into targeted approaches to cancer therapy, we aim to develop therapies that can more precisely eliminate tumour cells without harming healthy cells. We’re proud to share the latest updates in our ongoing blood cancer research at #IMS24. Learn more about our progress: https://gsk.to/3MSxyhw

We’re here in New York for #UNGA79 and #ClimateWeekNYC! Throughout the week, we’ll be addressing how we’re getting ahead of urgent challenges – from antimicrobial resistance to the impact of climate and nature loss on our health. Watch Claire Lund, our VP, Sustainability, as she shares how we’re working to create more sustainable healthcare that benefits both patients and the planet. Stay tuned for more updates and find out more about where our leaders will be making an impact: https://gsk.to/47HOrF5

We’re at #UNGA79 to share how through our work, we’re helping tackle some of the world’s biggest health challenges, including those that disproportionately affect people in lower income countries. Together with our partners, we’ll be exploring how we can drive further progress in the fight against infectious diseases like malaria and TB, what further challenges lie ahead that could hinder progress, and what more must be done to eliminate and control diseases driving AMR. Find out more: https://gsk.to/47BvEv0